Tampa (Fla.) General Hospital has become the first health system in Florida to adopt the Liberty endovascular robotic system.
Liberty is the only FDA-cleared, single-use, remotely operated robotic system for peripheral endovascular procedures, according to a Feb. 24 news release. The hospital’s adoption follows the device’s FDA 510(k) clearance and marks early post-clearance market activity.
About 2.5 million peripheral endovascular procedures are performed annually in the U.S., according to the release. Microbot Medical, developer of Liberty, began a limited market release in late 2025 and plans a full release at the Society of Interventional Radiology conference in April 2026.
